Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Prepaid Assets (2016 - 2025)

Sangamo Therapeutics has reported Prepaid Assets over the past 16 years, most recently at $4.4 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $4.4 million for Q4 2025, down 15.57% from a year ago — trailing twelve months through Dec 2025 was $4.4 million (down 15.57% YoY), and the annual figure for FY2025 was $4.4 million, down 15.57%.
  • Prepaid Assets for Q4 2025 was $4.4 million at Sangamo Therapeutics, down from $8.4 million in the prior quarter.
  • Over the last five years, Prepaid Assets for SGMO hit a ceiling of $21.1 million in Q2 2022 and a floor of $4.4 million in Q4 2025.
  • Median Prepaid Assets over the past 5 years was $12.6 million (2023), compared with a mean of $12.3 million.
  • Biggest five-year swings in Prepaid Assets: skyrocketed 146.65% in 2021 and later plummeted 49.19% in 2023.
  • Sangamo Therapeutics' Prepaid Assets stood at $15.9 million in 2021, then grew by 14.91% to $18.2 million in 2022, then tumbled by 49.19% to $9.3 million in 2023, then plummeted by 44.11% to $5.2 million in 2024, then decreased by 15.57% to $4.4 million in 2025.
  • The last three reported values for Prepaid Assets were $4.4 million (Q4 2025), $8.4 million (Q3 2025), and $6.6 million (Q2 2025) per Business Quant data.